Telomere Therapeutics, S.L aims to create gene therapy treatments for diseases linked to telomeric syndromes like pulmonary fibrosis and aplastic anemia. Their focus is on developing innovative solutions for conditions such as dyskeratosis congenita, offering hope to patients in need of advanced medical interventions.
National Ranking36th
in Spain Regional Ranking414th
in Western Europe Global Ranking2214th
worldwide Rankings by